University of Florence professor awarded ESCEO-IOF Servier Pierre D. Delmas Prize

Published on April 18, 2013 at 8:46 AM · No Comments

Award presented in Rome to honour researcher's work in cellular and molecular endocrinology as related to bone and mineral metabolism

Today, at the opening of the European Congress on Osteoporosis & Osteoarthritis in Rome, Italy, Professor Maria Luisa Brandi MD, Professor of Endocrinology and Metabolic Diseases at the University of Florence, Florence, Italy was presented with ESCEO-IOF Servier Pierre D. Delmas Prize.

The prestigious award, valued at -40,000, is granted by the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF) with the support of Servier.

"This award honours an individual who has made outstanding and major scientific contributions to the study of bone and mineral diseases. We are delighted to present the award to Professor Brandi, one of the most distinguished researchers in the field," said ESCEO President Professor Jean-Yves Reginster.

The award is named after the late Pierre Delmas, the renowned researcher and founding IOF President who was Professor of Medicine and Rheumatology at the University of Lyon, France and Director of the INSERM research unit 'Pathophysiology of Osteoporosis'.

IOF President John A. Kanis commented, "Professor Brandi has made essential contributions to research in clinical and basic bone and mineral metabolism, endocrine tumors, genetics, and in rare skeletal diseases. She has also worked to benefit osteoporosis advocacy in Italy and worldwide in her role as President of F.I.R.M.O. and as an active member of the International Osteoporosis Foundation."

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Pain control in osteoarthritis patients: an interview with Dr. Clarence Young, Chief Medical Officer and John Vavricka, President and CEO, Iroko Pharmaceuticals